‘Public-private’ deal heralds revolution in search for new drug treatments

GlaxoSmithKline and non-profit institutes hope to fast-track research into cures using patient DNA

Science Editor

Britain’s biggest drug company has signed a pioneering deal with two public research institutes to develop new medicines based on patient DNA in the hope of discovering lucrative treatments for a range of illnesses with a genetic basis, from cancer to heart disease.

GlaxoSmithKline (GSK) has promised to publicly release any early research findings for free in return for the expertise and help offered by the Wellcome Trust Sanger Institute, where the human genome was decoded, and the European Bioinformatics Institute (EBI), both based on the same campus in Cambridge.

The aim of the unique collaboration is to identify potential targets in the body for new drugs based on an analysis of the huge volumes of data generated by the human genome and similar studies into complex biological molecules such as proteins and peptides.

In return for its investment, GSK hopes to steal a march on its competitors by identifying targets early enough for it to develop drugs that have less risk of failure at the early stages of clinical trials, said Ewan Birney, associate director of the EBI and the interim head of the new Centre for Therapeutic Target Validation.

“This is about enlightened self-interest. They are funding public research to do the groundwork in the earliest stage of drug discovery. They really want to change the game for this early part of the drug-discovery process,” Dr Birney said.

“They are backing themselves that they can do the next phase and find the right drug that works better than anyone else. They realised that some things are better solved in the public domain,” he said.

One of the preconditions of the collaboration is that the research findings will be freely available, but GSK can direct the research towards areas where the company already has a commercial interest, Dr Birney said.

It is estimated that about nine out of 10 potential new drugs fail when they enter clinical trials even though they have shown promise in the laboratory and in animal trials. 

Another problem is that even many licensed drugs do not work on all potential patients - some people do not respond because of their genetic makeup. It is one of the best-kept secrets of the pharmaceuticals industry that most of the drugs it makes do not work on most of the patients they are designed for.

“We are interested in knowing the proteins to target for drugs. In the case of responders and non-responders, were interested really in the new proteins in the non-responders which look like the right ones to target,” Dr Birney said.

The Sanger Institute is a world leader in decoding and analysing genome data while the EBI’s area of expertise is handling the huge volume of data generated by genome science, as well as new research in proteomics (proteins science), biochemistry and the biological basis of disease.

The centre will be built on the same site in Cambridge where the Sanger Institute is based and will initially employ about 50 researchers.

Patrick Vallance, president of pharmaceuticals research and development at GSK, said that by changing its business model and sharing information in a collaborative way, the company hopes to accelerate the development of new medicines.

“Target validation is one of the greatest challenges in drug discovery. We need to understand better the mechanisms in our body related to disease to improve how we can develop the most effective mechanisms,” Dr Vallance said.

Professor Sir Mike Stratton, director of the Sanger Institute, said: “Advances in genomics have led to a rapid increase in the availability of drug targets, providing enormous opportunity but also posing the problem of how we best convert this knowledge into medicines.

“The challenge we now address it to identify those new targets with the greatest relevance to human disease which, in turn, will undoubtedly increase the speed and efficiency in which new medicines can be developed.”

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Senior Environmental Adviser - Maternity Cover

£37040 - £43600 per annum: Recruitment Genius: The UK's export credit agency a...

Recruitment Genius: CBM & Lubrication Technician

£25000 - £27500 per annum: Recruitment Genius: This company provides a compreh...

Recruitment Genius: Care Worker - Residential Emergency Service

£16800 - £19500 per annum: Recruitment Genius: Would you like to join an organ...

Recruitment Genius: Senior Landscaper

£25000 - £28000 per annum: Recruitment Genius: In the last five years this com...

Day In a Page

The long walk west: they fled war in Syria, only to get held up in Hungary – now hundreds of refugees have set off on foot for Austria

They fled war in Syria...

...only to get stuck and sidetracked in Hungary
From The Prisoner to Mad Men, elaborate title sequences are one of the keys to a great TV series

Title sequences: From The Prisoner to Mad Men

Elaborate title sequences are one of the keys to a great TV series. But why does the art form have such a chequered history?
Giorgio Armani Beauty's fabric-inspired foundations: Get back to basics this autumn

Giorgio Armani Beauty's foundations

Sumptuous fabrics meet luscious cosmetics for this elegant look
From stowaways to Operation Stack: Life in a transcontinental lorry cab

Life from the inside of a trucker's cab

From stowaways to Operation Stack, it's a challenging time to be a trucker heading to and from the Continent
Kelis interview: The songwriter and sauce-maker on cooking for Pharrell and crying over potatoes

Kelis interview

The singer and sauce-maker on cooking for Pharrell
Refugee crisis: David Cameron lowered the flag for the dead king of Saudi Arabia - will he do the same honour for little Aylan Kurdi?

Cameron lowered the flag for the dead king of Saudi Arabia...

But will he do the same honour for little Aylan Kurdi, asks Robert Fisk
Our leaders lack courage in this refugee crisis. We are shamed by our European neighbours

Our leaders lack courage in this refugee crisis. We are shamed by our European neighbours

Humanity must be at the heart of politics, says Jeremy Corbyn
Joe Biden's 'tease tour': Could the US Vice-President be testing the water for a presidential run?

Joe Biden's 'tease tour'

Could the US Vice-President be testing the water for a presidential run?
Britain's 24-hour culture: With the 'leisured society' a distant dream we're working longer and less regular hours than ever

Britain's 24-hour culture

With the 'leisured society' a distant dream we're working longer and less regular hours than ever
Diplomacy board game: Treachery is the way to win - which makes it just like the real thing

The addictive nature of Diplomacy

Bullying, betrayal, aggression – it may be just a board game, but the family that plays Diplomacy may never look at each other in the same way again
Lady Chatterley's Lover: Racy underwear for fans of DH Lawrence's equally racy tome

Fashion: Ooh, Lady Chatterley!

Take inspiration from DH Lawrence's racy tome with equally racy underwear
8 best children's clocks

Tick-tock: 8 best children's clocks

Whether you’re teaching them to tell the time or putting the finishing touches to a nursery, there’s a ticker for that
Charlie Austin: Queens Park Rangers striker says ‘If the move is not right, I’m not going’

Charlie Austin: ‘If the move is not right, I’m not going’

After hitting 18 goals in the Premier League last season, the QPR striker was the great non-deal of transfer deadline day. But he says he'd preferred another shot at promotion
Isis profits from destruction of antiquities by selling relics to dealers - and then blowing up the buildings they come from to conceal the evidence of looting

How Isis profits from destruction of antiquities

Robert Fisk on the terrorist group's manipulation of the market to increase the price of artefacts
Labour leadership: Andy Burnham urges Jeremy Corbyn voters to think again in last-minute plea

'If we lose touch we’ll end up with two decades of the Tories'

In an exclusive interview, Andy Burnham urges Jeremy Corbyn voters to think again in last-minute plea